Explore more publications!

Automotive Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Press Releases.

Press releases published on October 27, 2025

The Capital Link Investigates: Opioid Story Retraction, Claims Unverified
Volaris Reports Financial Results for the Third Quarter 2025: EBITDAR Margin of 33.6%
Plastic Pigment Market Booming Worldwide with Latest Trend and Future Scope by 2032
Volatus Aerospace Acquires Strategic Dual-Use UAS Technology to Support Canada’s Sovereign Capability and Allied Defense Requirements Worldwide
Volatus Aerospace acquiert une technologie stratégique de drones à double usage pour soutenir la capacité souveraine du Canada et les besoins de défense alliés à l'échelle mondiale
BlackRock® Canada Announces Final October Cash Distributions for the iShares® Premium Money Market ETF
JHX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of James Hardie Industries plc Investors
Magnera to Report Fourth Quarter and Fiscal Year 2025 Results on November 20th
Cycurion, Inc. Announces Successful Completion of 1-for-30 Reverse Stock Split
Ferrellgas, L.P. Announces Closing of Senior Notes Offering and Entry Into Credit Agreement Amendment
ArcelorMittal announces the publication of its third quarter 2025 sell-side analyst consensus figures
Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP
Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI
QTUM – The Defiance Quantum Computing ETF – Tops $3 Billion AUM, Maintains 5-Star Morningstar Rating Amid Quantum Boom
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
Holley Performance Brands Achieves $100 Million in Debt Reduction Over the Last Two Years
Advisory: Fortis Inc. to Hold Teleconference on November 4 to Discuss Third Quarter 2025 Results  and New Five-Year Capital Outlook
3D Systems Announces Major Milestones in Saudi Arabian Growth Initiative

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions